β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 44 β 19 MAY 2016
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Duavive
Bazedoxifene acetate 22.56mg equivalent to 20mg bazedoxifene
Conjugated estrogens 0.45mg
Modified release tablet
Pfizer New Zealand Limited
Pfizer Ireland Pharmaceuticals, Newbridge, Ireland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Visanne
Dienogest 2mg
Tablet
Bayer New Zealand Limited
Bayer Weimar GmbH und Co KG, Weimar, Germany
Dated this 13th day of May 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go2816
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Act-HIB vaccine
Haemophilus influenzae type b vaccine 10mcg
Powder for injection with diluent
Sanofi-Aventis New Zealand Limited
Sanofi Pasteur SA, Marcy LβEtoile, France
Sanofi-Aventis SpA, Frosinone, Italy
Sanofi Pasteur SA, Val-De-Reuil Cedex, France
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Augmentin
Amoxicillin sodium 530.1mg equivalent to Amoxicillin 500mg
Potassium clavulanate 119.13mg equivalent to Clavulanic acid 100mg
Powder for injection
GlaxoSmithKline (NZ) Limited
SmithKline Beecham Pharmaceuticals Limited, West Sussex, United Kingdom
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Augmentin
Amoxicillin sodium 1060.2mg equivalent to Amoxicillin 1000mg
Potassium clavulanate 238.25mg equivalent to Clavulanic acid 200mg
Powder for injection
GlaxoSmithKline (NZ) Limited
SmithKline Beecham Pharmaceuticals Limited, West Sussex, United Kingdom
Dated this 13th day of May 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go2817
Renewal of Provisional Consent to the Distribution of Medicine
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
132
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare13 May 2016
Medicines, Distribution, Consent, Duavive, Visanne
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of New Medicines (Act-HIB vaccine and Augmentin)
π₯ Health & Social Welfare13 May 2016
Medicines, Distribution, Consent, Act-HIB vaccine, Augmentin
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Renewal of Provisional Consent to the Distribution of Medicine
π₯ Health & Social Welfare13 May 2016
Medicines, Distribution, Renewal, Provisional Consent
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2016, No 44